Publikationen, an denen er mitarbeitet Enrique Aranda Aguilar (27)

2023

  1. Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized Trials

    Clinical Colorectal Cancer, Vol. 22, Núm. 2, pp. 222-230

2021

  1. Early clinical experience with trifluridine/tipiracil for refractory metastatic colorectal cancer: The ros study

    Cancers, Vol. 13, Núm. 18

  2. Implementation of the Quality Oncology Practice Initiative Program in Spain: First Results and Implications

    JCO oncology practice, Vol. 17, Núm. 8, pp. e1162-e1169

2019

  1. Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer (Scientific Reports, (2019), 9, 1, (2589), 10.1038/s41598-019-39291-2)

    Scientific Reports

  2. Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: An expert taskforce review

    Annals of Oncology, Vol. 28, Núm. 12, pp. 2943-2949

2006

  1. Effects of single or repeated intravenous administration of kisspeptin upon dynamic LH secretion in conscious male rats

    Endocrinology, Vol. 147, Núm. 6, pp. 2696-2704

  2. Hypothalamic expression of KiSS-1 system and gonadotropin-releasing effects of kisspeptin in different reproductive states of the female rat

    Endocrinology, Vol. 147, Núm. 6, pp. 2864-2878

2005

  1. Changes in hypothalamic KiSS-1 system and restoration of pubertal activation of the reproductive axis by kisspeptin in undernutrition

    Endocrinology, Vol. 146, Núm. 9, pp. 3917-3925

  2. Effects of KiSS-1 peptide, the natural ligand of GPR54, on follicle-stimulating hormone secretion in the rat

    Endocrinology, Vol. 146, Núm. 4, pp. 1689-1697

  3. Effects of chronic hyperghrelinemia on puberty onset and pregnancy outcome in the rat

    Endocrinology, Vol. 146, Núm. 7, pp. 3018-3025

  4. Expression of growth hormone secretagogue receptor type 1a, the functional ghrelin receptor, in human ovarian surface epithelium, mullerian duct derivatives, and ovarian tumors

    Journal of Clinical Endocrinology and Metabolism, Vol. 90, Núm. 3, pp. 1798-1804

2004

  1. Anti-emetic efficacy of oral granisetron in the total control of late-onset emesis induced by cyclophosphamide-containing chemotherapy

    Revista de oncología: Publicación oficial de la Federación de Sociedades Españolas de Oncología y del Instituto Nacional de Cancerología de México, Vol. 6, Núm. 1, pp. 22-29

  2. Expression of Ghrelin and Its Functional Receptor, the Type 1a Growth Hormone Secretagogue Receptor, in Normal Human Testis and Testicular Tumors

    Journal of Clinical Endocrinology and Metabolism, Vol. 89, Núm. 1, pp. 400-409

  3. Novel expression of resistin in rat testis: Functional role and regulation by nutritional status and hormonal factors

    Journal of Cell Science, Vol. 117, Núm. 15, pp. 3247-3257

2003

  1. Developmental, stage-specific, and hormonally regulated expression of growth hormone secretagogue receptor messenger RNA in rat testis

    Biology of Reproduction, Vol. 68, Núm. 5, pp. 1631-1640

  2. Expression of ghrelin in the cyclic and pregnant rat ovary

    Endocrinology, Vol. 144, Núm. 4, pp. 1594-1602

  3. Immunolocalization of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in the cyclic human ovary

    Journal of Clinical Endocrinology and Metabolism, Vol. 88, Núm. 2, pp. 879-887

2002

  1. Cellular location and hormonal regulation of ghrelin expression in rat testis

    Biology of Reproduction, Vol. 67, Núm. 6, pp. 1768-1776

  2. Novel expression and functional role of ghrelin in rat testis

    Endocrinology, Vol. 143, Núm. 2, pp. 717-725